The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Ozempic is primarily used for managing type 2 diabetes, whereas Wegovy is specifically approved for weight loss. Who is it for? Wegovy is approved for adults with a body mass index (BMI ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...